Reston Hospital Center, a part of US-based healthcare network HCA Virginia, has opened an inpatient unit at its main hospital ...

Bristow's report suggests that the current share price does not account for the potential success of subsequent programs, including those for head and neck squamous cell carcinoma (HNSCC), ...

The cost of cancer may be higher than previously estimated, according to a recent report from the American Cancer Society.

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing medicines targeting metalloenzymes, announced today that it will present preclinical data on its ...

Biotechnology sits at a fascinating crossroads. As scientific advances uncover the shared mechanisms of oncology and immunology, the traditional boundaries in how we perceive and treat these ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...